Source: FirstWord Pharma

Acacia Pharma: Acacia Pharma to Postpone Publication of its Results for the Full Year 2021, Scheduled on 31 March 2022

THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION Not for release, publication or distribution, in whole or in part, directly or indirectly in, into or from any jurisdiction where to do so would...

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Michael Bolinder's photo - CEO of Acacia Pharma

CEO

Michael Bolinder

CEO Approval Rating

90/100

Read more